Industry Focus
Healthcare: Is Celgene Going To Buy Juno Therapeutics?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:27:57
- Mas informaciones
Informações:
Sinopsis
Rumors are swirling that Celgene may pay billions to buy Juno Therapeutics lock-stock-and-barrel. Do these rumors make sense? Also, how one tiny company is disrupting the $57 billion market for primary and specialty doctor visits. Is this healthcare's future?
